Pentachlorophenol decreases tumor-cell-binding capacity and cell-surface protein expression of human natural killer

Tasia Hurd1, Jasmine Walker, Margaret M Whalen

  • 1Department of Biological Sciences, Tennessee State University, Nashville, TN 37209, USA.

Insights

Pentachlorophenol (PCP) pesticide exposure impairs human natural killer (NK) cell function by reducing their ability to bind to tumor cells. This decreased binding is linked to lower expression of crucial cell-surface proteins, potentially explaining NK cell dysfunction.

Area of Science:

  • Immunology
  • Environmental Toxicology
  • Cell Biology

Background:

  • Natural killer (NK) cells are crucial for immune surveillance against tumors and virally infected cells.
  • Pentachlorophenol (PCP), an organochlorine pesticide, is known to suppress NK cell lytic function.
  • The mechanisms by which PCP affects NK cell activity, particularly binding to target cells, require further elucidation.

Purpose of the Study:

  • To investigate the impact of PCP on the binding function of human NK cells to tumor targets.
  • To determine the effects of PCP exposure on the expression of cell-surface proteins essential for NK cell binding.
  • To correlate changes in NK cell binding and surface protein expression with the pesticide's known effects on lytic function.

Main Methods:

  • Human NK cells were exposed to varying concentrations and durations of PCP.
  • NK cell binding to tumor targets was quantified.
  • Flow cytometry was used to measure the expression levels of cell-surface proteins, including CD11a and CD56.

Main Results:

  • Exposure to 10 microM PCP for 24 hours significantly reduced NK cell lytic function by over 70%.
  • This exposure also decreased NK cell binding function by 34.6% and the expression of CD11a and CD56 proteins by 21.7% and 26.2%, respectively.
  • Lower concentrations of PCP over longer periods also led to decreased binding function and cell-surface protein expression.

Conclusions:

  • Continuous PCP exposure impairs NK cell binding function and reduces the expression of critical cell-surface markers.
  • These alterations in binding and surface protein expression likely contribute to the observed decrease in NK cell lytic function.
  • The findings suggest that PCP-induced NK cell dysfunction, due to reduced tumor cell binding, may partially explain the increased cancer risk associated with PCP exposure in humans.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...